| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.35 | 0.06 |